Sara Guariglia,  —

Sara earned her Ph.D. from the City University of New York Graduate Center in Biology, where she studied Developmental Neurotoxicology. She currently works as a Research Scientist, Professor, and School Administrator in New York City.

Articles by

DTx Pharma Receives NIH Funding to Advance RNA-based Therapies for CMT

The National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health (NIH), has awarded DTx Pharma a funding grant to advance development of promising new therapeutic candidates for Charcot-Marie-Tooth (CMT) type 1A (CMT1A) disease. The therapeutic candidates are specially designed RNA oligonucleotide…